News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Solvay Chemicals Inc. Sells Caprolactones Unit for 200 Million Euros



10/15/2007 9:02:21 AM

BRUSSELS, Oct 15 (Reuters) - Belgian drugs, chemicals and plastics maker Solvay (SOLB.BR: Quote, Profile, Research) said on Monday it had sold its Caprolactones business for 200 million euros ($284.3 million) to Sweden's Perstorp Group.

Read at Reuters


comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES